- Rating
- 1
- Confidence
- 4
- Informativeness
- 1
- Presentation
- 3
- Soundness
- 1
Read review
Paper summary
The paper proposes GLoDe, a histology-to-spatial-transcriptomics prediction framework that decomposes gene expression into a slide-level baseline and spot-specific residuals. It combines pretrained pathology and gene embeddings with spatial attention and gene-conditioned decoding.
Critical strengths
Addresses a relevant biological prediction problem.
Critical weaknesses
-
Limited methodological novelty. Hierarchical modeling on this problem has been long existing.
-
Small datasets and weak generalization evidence. Several cohorts contain only 2–4 slides. Despite the large number of spatial spots, the number of independent biological samples is very limited, raising concerns about overfitting and the reliability of the reported generalization results.
-
Limited gene coverage. The main HEST-1K experiments evaluate only 50 selected genes, a critical detail relegated to the appendix. Performance on such a small panel does not adequately characterize transcriptome-wide prediction quality or generalization across genes.
-
Questionable baseline comparability. STPath supports more than 30k genes but is evaluated without fine-tuning, whereas GLoDe is specifically trained on small gene panels. Although the authors report matched evaluation panels, differences in training protocols and gene coverage complicate the comparison. The fairness of the reported improvements is insufficiently established.
Questions for authors
- How reliable are the generalization claims given that several cohorts contain only 2–4 slides?
- How does GLoDe perform on substantially larger gene panels, including low-expression and less-variable genes?
- Why is STPath evaluated without fine-tuning, and how are differences in training protocols, gene coverage, and expression preprocessing controlled?